Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery

NEWARK, Calif. -- Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation assay-based solutions, today announced that they have signed an agreement. This collaboration aims to develop cutting-edge biomarker discovery tools, allowing detection of specific protein glycosylation in tissue samples for the first time. Product launches are scheduled for 2025. Read More